[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"patient-participation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:patient-participation":32},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,79,118,147,191,221,250,277],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":43,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":78},"100643981","health-ahead-comparative-effectiveness-study-100643981",false,"NCT07669168","Health Ahead Comparative Effectiveness Study","Health Ahead: Sequential Comparative-Effectiveness Studies Toward Automated, Universally Deployable Preventive Health Screening","HACE","Inclusion Criteria:\n\n* Age 18 years or older\n* Willing and able to provide written informed consent, or enrollment with consent of a legally authorized representative\n* Willing to participate in longitudinal follow-up.\n\nExclusion Criteria:\n\n\\- Age under 18 years.",true,"ALL","18 Years",{"count":21,"type":22},1000000,"ESTIMATED","INTERVENTIONAL",[25],"NA","The Health Ahead Comparative Effectiveness Study is a pragmatic, parallel-arm interventional platform that systematically compares successive changes to preventive health screening - each isolated as a single variable against current practice - on the path toward a fully automated screening system deployable in any environment, including the most isolated and resource-limited communities. Each comparison is evaluated with a common set of engagement, behavior-change, experience, cost, and longitudinal outcome measures, allowing results to accumulate on a consistent yardstick across the life of the platform.\n\nThe first comparison evaluates static versus interactive personalized health report delivery. Subsequent pre-planned comparisons, added by protocol amendment, evaluate mobile community versus fixed laboratory screening; and a hybrid medical-droid plus human-delivery model versus human-only screening. All participants are simultaneously enrolled in the 100-Year Human Aging Study and the Human Observatory Study, contributing individual longitudinal and population-level causal inference data through those protocols.",[28,29,30,31,32,33,34,35,36,37,38,39,40,41,42],"Health Services Accessibility","Rural Health","Medically Underserved Area","Preventive Health Services","Patient Participation","Health Behavior","Aging","Cardiovascular Diseases","Metabolic Syndrome","Cognitive Dysfunction","Frailty","Activities of Daily Living","Health Related Quality of Life","Health Equity","Telemedecine",[44,45,46,47,48,41,29,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65],"Sequential Platform Trial","Interactive Health Report","Health Activation","Mobile Health Screening","Comparative Effectiveness","Medically Underserved","Preventive Medicine","Patient Engagement","Cardiopulmonary Exercise Testing","Body Composition","DEXA","Health Ahead Bus","Mobile Clinic","Automated Screening","Medical Droids","Biological Age","Healthspan","Longevity","Life Expectancy","Chronic Disease","Cost-Effectiveness","Health Services Research","RECRUITING","2026-06-20",{"date":69,"type":70},"2026-06-25","ACTUAL",{"date":72,"type":22},"2026-06-09",{"date":74,"type":22},"2099-12-31",{"name":76,"class":77},"William Brandenburg, MD","INDUSTRY",1,{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":85,"eligibilityCriteria":86,"healthyVolunteers":17,"sex":18,"minAge":87,"maxAge":4,"enrollmentInfo":88,"targetDuration":4,"studyType":23,"phases":90,"briefSummary":91,"conditions":92,"keywords":98,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":117},"100571599","palliative-care-education-in-assisted-living-for-dementia-care-providers-pceal-dcp-100571599","NCT06722352","Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)","Preparing Assisted Living Staff to Provider Palliative Care to Residents With Dementia: Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)","PCEAL-DCP","Inclusion Criteria:\n\nThe AL community eligibility criteria include a minimum of 40+ beds and provide memory care services to at least 35% of their residents, and access to hospice services from Lifepath or Suncoast Hospice. The AL size of 40+ beds is selected so we will be able to recruit a minimum of 14 residents per site, based on the power analysis for the sample size of 450 for the primary study outcome of documentation of ACP discussions.\n\nResidents are eligible if 1) they have a dementia diagnosis confirmed by the resident's physician (physician's signature required by University of South Florida (USF) Institutional Reiew Board (IRB) in prior clinical trial) regardless of dementia severity (mild, moderate, or severe), 2) if they have been admitted to the AL in the last month, and 3) if they have a legally responsible representative who understands English.\n\nStaff are eligible if they are currently employed with the participating study AL as a registered\u002Flicensed practical nurse, administrator, or dementia care coordinator of a memory care unit and English speaking and 21 years of age or older.\n\nFamily members are eligible if 1) they are listed as the legally responsible party in the chart records for the resident with ADRD, 2) they understand English, and 3) are at least 21 years of age or older. This could include someone related to the person, a close friend or a legal guardian who oversees the person's care and is responsible for decisions about their care.\n\nExclusion Criteria:\n\nAL sites will be ineligible if 1) the are not a licensed Florida assisted living facility; 2) they have previously participated in a PCEAL-DCP clinical trial (2018-2021) to avoid possible experimental contamination effects, and 3) if no staff employed at the AL are willing to participate in the study.\n\nResidents are ineligible if they: 1) are currently receiving hospice services because residents who receive hospice are already engaged in ACP discussions upon admission; 2) if they are discharged from assisted living to another setting (nursing home or hospital) or are admitted to hospice or have died before baseline data is collected.\n\nStaff will be ineligible if they are not licensed nurses, administrators or dementia care coordinators of a dementia care unit or terminated\u002Fresign before baseline data is collected.\n\nFamily are ineligible if: 1) they are under 21 years of age and do not understand spoken or written English and if there is already a legal authorized representative for a resident participating in the study (one family member per resident).\n\n\\-","21 Years",{"count":89,"type":22},792,[25],"The palliative care education in assisted living for dementia care providers (PCEAL-DCP) is a 4-week intervention (once a week for 1.5 hours, a total of 6 hours) for licensed nurses, administrators and dementia care coordinators to improve quality of dementia care outcomes",[93,94,95,96,32,97],"Alzheimer Disease","End of Life","Caregiver Burden","Caregiver Burnout","Self Efficacy",[99,100,101,102,103,104,105,106],"end of life","palliative care","education","staff training","assisted living","dementia","dementia care","Alzheimer's","2026-04-27",{"date":109,"type":70},"2026-04-29",{"date":111,"type":70},"2025-01-28",{"date":113,"type":22},"2029-08-01",{"name":115,"class":116},"University of South Florida","OTHER",2,{"id":119,"slug":120,"hasResults":11,"nctId":121,"briefTitle":122,"officialTitle":123,"acronym":4,"eligibilityCriteria":124,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":125,"enrollmentInfo":126,"targetDuration":4,"studyType":23,"phases":128,"briefSummary":129,"conditions":130,"keywords":134,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":141,"completionDateStruct":143,"leadSponsor":145,"locationsCount":78},"100570192","healthrelated-quality-of-life-and-experiences-of-a-heart-rehabilitation-programme-after-care-for-infective-endocarditis-100570192","NCT06704048","Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.","Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis. A Quantitave and Qualitative Study With Mixed Methods.","Inclusion Criteria:\n\n* Diagnosis of infective endocarditis (IE) based on Dukes ISCVID criteria and discharged after treatment for IE from the Department of Infectious Diseases, Hospital of Halmstad, Region Halland, Sweden.\n\nExclusion Criteria:\n\n* Not able to do a bicycle ergometer test or training.","90 Years",{"count":127,"type":22},50,[25],"How does health develop after Infective endocarditis (IE)? Can the health of patients with IE be improved by participation in the physical exercise training within cardiac rehabilitation program?\n\nParticipants will:\n\n* Answer digitally surveys on the perceived health for 4 times during 1 year\n* Participate in interviews on patient's experiences of health and rehabilitation 1 time before and 2 times after the training program during I year.\n* Be physically evaluated by a physiotherapist before and after the progam of physical exercise training within cardiac rehabilitation.\n* Do individual exercises in a group led by a physiotherapist 2 times weekly during 12 weeks.",[131,132,133,32],"Infective Endocarditis","Bacterial Infections","Cardiac Rehabilitation",[131,132,32,135,136,137],"Interview","Qualitative Research","Cardiac rehabilitation","2026-04-01",{"date":140,"type":70},"2026-04-07",{"date":142,"type":70},"2024-08-22",{"date":144,"type":22},"2035-08",{"name":146,"class":116},"Region Halland",{"id":148,"slug":149,"hasResults":11,"nctId":150,"briefTitle":151,"officialTitle":151,"acronym":152,"eligibilityCriteria":153,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":154,"targetDuration":4,"studyType":23,"phases":156,"briefSummary":157,"conditions":158,"keywords":181,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":182,"lastUpdatePostDateStruct":183,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":78},"100585650","digital-transformation-of-continuity-of-care-for-peripherally-inserted-central-catheters-spadcare-experience-100585650","NCT06905119","Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience","SpadCare","Inclusion Criteria:\n\n* Patients \\>18 years.\n* Sign the informed consent form.\n* Have a Smartphone and accept the use of the APP.\n* Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month.\n\nExclusion Criteria:\n\n* Patients with limitations in the use of digital resources or lack of Smartphone.\n* Patients who do not want to install the APP on their Smartphone\n* Patients who do not authorize access to their Computerized Medical Record (HCI).",{"count":155,"type":22},201,[25],"The study focuses on patients who require outpatient infusion of therapy (\"Infusions, Intravenous\"\\[Mesh\\]) \"Administration, Intravenous\"\\[Mesh\\] (\"Home Infusion Therapy\"\\[Mesh\\]) \"Parenteral Nutrition, Home\"\\[Mesh\\] via a peripherally inserted central catheter (PICC) (\"Central Venous Catheters\"\\[MeSH\\] \"Catheterization, Central Venous\"\\[MeSH\\] \"Catheterization, Peripheral\" \\[MeSH\\] \"Vascular Access Devices\"\\[Mesh\\] )",[159,160,161,162,163,164,165,166,167,32,168,169,170,171,172,173,174,175,176,177,178,179,180],"Infusions, Intravenous","Administration, Intravenous","Home Infusion Therapy","Parenteral Nutrition, Home","Central Venous Catheters","Catheterization, Central Venous","Catheterization, Peripheral","Vascular Access Devices","Patient Education as Topic","User-Computer Interface","Smartphone","Mobile Applications","Computers, Handheld","Digital Health","Nursing","Care Givers","Delivery of Health Care","Home Nursing","Self Administration","Adverse Effects","Catheter-Related Infections","Telemedicine",[165,166,167,180,170],"2025-09-11",{"date":184,"type":70},"2025-09-12",{"date":186,"type":70},"2023-05-04",{"date":188,"type":22},"2026-07-31",{"name":190,"class":116},"Fundacion Miguel Servet",{"id":192,"slug":193,"hasResults":11,"nctId":194,"briefTitle":195,"officialTitle":196,"acronym":4,"eligibilityCriteria":197,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":198,"enrollmentInfo":199,"targetDuration":4,"studyType":23,"phases":201,"briefSummary":202,"conditions":203,"keywords":207,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":211,"lastUpdatePostDateStruct":212,"startDateStruct":214,"completionDateStruct":216,"leadSponsor":218,"locationsCount":78},"100542003","tcm-therapy-program-impact-on-breast-cancer-patients-vital-energy-100542003","NCT06337214","TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy","A Holistic Medical Approach - The Effect of \"Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy\" on Breast Cancer Patients Undergoing Cancer Therapy","Inclusion Criteria:\n\n* Individuals aged 18 years and above and below 85 years, willing to voluntarily participate in the study.\n* Diagnosed with malignant breast tumors, ICD-10: C50, by conventional medicine.\n* Patients currently undergoing cancer treatment, including chemotherapy, radiotherapy, or targeted therapy.\n\nExclusion Criteria:\n\n* Diagnosed solely with carcinoma in situ or benign tumors, including fibrocystic breast conditions, by conventional medicine.\n* Patients regularly receiving Astragalus polysaccharide injections.\n* Patients with a history of allergies to Traditional Chinese Medicine.\n* Pregnant or breastfeeding women.\n* Individuals with a drug addiction habit, including both narcotic and non-narcotic drugs.\n* Any other situation where the participant is unable to cooperate (e.g., due to any factor that prevents participation, deemed unsuitable for participation by study staff, unwillingness to sign the consent form).","85 Years",{"count":200,"type":22},80,[25],"The goal of this study is to evaluate the impact of the \"Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy\" on patients with breast cancer who are currently undergoing conventional Western medical treatments in Taiwan. The main questions it aims to answer are:\n\nCan the \"Traditional Chinese Medicine Therapy Program\" alleviate symptoms experienced by breast cancer patients? Does the program improve the quality of life for breast cancer patients receiving Western medical treatments? How does the program contribute to the management of side effects associated with Western oncological therapies?\n\nParticipants will:\n\nEngage in the \"Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy\" provided by the Taiwan Compassionate Cancer Care Association.\n\nReceive supportive and educational services, including auxiliary Chinese medicine treatment courses, lifestyle and health education, and psychological counseling.\n\nThis study seeks to integrate the concept of holistic healthcare, emphasizing coordinated care that encompasses physical, mental, and social aspects, into the treatment of breast cancer.",[204,205,32,206],"Breast Cancer","Neoplasm, Breast","Mental Health Issue",[204,208,209,210],"Reinforcing Vital Energy","Patients Association","Patients Educatioin","2025-05-31",{"date":213,"type":70},"2025-06-04",{"date":215,"type":70},"2024-03-13",{"date":217,"type":22},"2025-12-31",{"name":219,"class":220},"Taipei City Hospital","OTHER_GOV",{"id":222,"slug":223,"hasResults":11,"nctId":224,"briefTitle":225,"officialTitle":226,"acronym":227,"eligibilityCriteria":228,"healthyVolunteers":17,"sex":18,"minAge":229,"maxAge":4,"enrollmentInfo":230,"targetDuration":4,"studyType":23,"phases":232,"briefSummary":233,"conditions":234,"keywords":236,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":241,"lastUpdatePostDateStruct":242,"startDateStruct":244,"completionDateStruct":246,"leadSponsor":248,"locationsCount":117},"100505823","clean-hands-accessible-and-manageable-for-patients-champs-100505823","NCT05866393","Clean Hands Accessible and Manageable for Patients (CHAMPs)","Clean Hands Accessible and Manageable for Patients (CHAMPs): A Technology-based Self-management Intervention to Improve Patient Hand Hygiene and Reduce Hand Contamination Among Older Adults","CHAMPs","Inclusion Criteria:\n\n1. \\> 65 years of age,\n2. Admitted to a medical-surgical unit,\n3. Expected to be hospitalized for more than 24 hours,\n4. Written informed consent within 24-48 hours of admission, and\n5. Speak and read English\n6. Physical capacity to use the CHAMPs system\n7. Sufficient hearing and seeing capacity to indicate understanding and use of the intervention.\n\nExclusion Criteria\n\n1. terminal illness that prohibit interaction with CHAMPs\n2. behavior disorder\n3. violent behavior\n4. physical or cognitive impairments that prohibit interaction with CHAMPs\n5. limiting understanding and use of CHAMPs\n6. undergoing radiation or chemotherapy that prohibit interaction with CHAMPs\n7. skin disorders or\n8. broken skin on hands.","65 Years",{"count":231,"type":22},250,[25],"This study proposes the novel use of a bedrail-affixed technology-based patient hand hygiene system with verbal and visual reminders to improve hospitalized older adults' self-management of hand hygiene practice, which in return reduces harmful germs found on older adult's hands that lead to infections.",[235,32,34],"Pathogen Transmission",[237,238,239,240],"patient hand hygiene","self-management","infection prevention and control","older adult","2025-05-02",{"date":243,"type":70},"2025-05-06",{"date":245,"type":70},"2023-08-17",{"date":247,"type":22},"2026-10-31",{"name":249,"class":116},"Case Western Reserve University",{"id":251,"slug":252,"hasResults":11,"nctId":253,"briefTitle":254,"officialTitle":254,"acronym":4,"eligibilityCriteria":255,"healthyVolunteers":11,"sex":18,"minAge":256,"maxAge":257,"enrollmentInfo":258,"targetDuration":4,"studyType":260,"phases":4,"briefSummary":261,"conditions":262,"keywords":264,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":268,"lastUpdatePostDateStruct":269,"startDateStruct":271,"completionDateStruct":273,"leadSponsor":275,"locationsCount":78},"100540855","promoting-childrens-participation-in-conventional-x-ray-examinations-100540855","NCT06322264","Promoting Children's Participation in Conventional X-ray Examinations","Inclusion Criteria:\n\n* Children ages 4-12 yrs who undergo standard x-ray examinations\n* parents to the child\n* assigned radiographers\n\nExclusion Criteria:\n\n* Children and parents who have cognitive and\u002For language difficulties","4 Years","12 Years",{"count":259,"type":22},220,"OBSERVATIONAL","The goal of this explorative observational study is to map the procedure and child centered approach in the examination for children that undergo conventional X-ray examinations. The main questions aim to answer:\n\n* How many images need to be retaken during conventional X-ray examinations?\n* What is the reason why the pictures need to be redone?\n* What is the time required for the various examinations?\n* What experience of the procedure of the examination is there among those involved?\n* Can the physical impact be observed through variation in heart rate in children that undergo conventional X-ray examinations?\n\nParticipants will answer questionnaires about the children's participation in the procedure and the variation in heart rate will be measured on the children who undergo the examinations.",[263,32],"Heart Rate Determination",[265,266,267],"Children's participation","Conventional x-ray procedure","Variation in heart rate","2025-04-15",{"date":270,"type":70},"2025-04-18",{"date":272,"type":70},"2024-11-05",{"date":274,"type":22},"2026-12-10",{"name":276,"class":116},"Lund University",{"id":278,"slug":279,"hasResults":11,"nctId":280,"briefTitle":281,"officialTitle":282,"acronym":283,"eligibilityCriteria":284,"healthyVolunteers":11,"sex":18,"minAge":285,"maxAge":286,"enrollmentInfo":287,"targetDuration":289,"studyType":260,"phases":4,"briefSummary":290,"conditions":291,"keywords":294,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":301,"lastUpdatePostDateStruct":302,"startDateStruct":304,"completionDateStruct":306,"leadSponsor":308,"locationsCount":78},"100412993","french-national-cohort-of-people-with-type-1-diabetes-100412993","NCT04657783","French National Cohort of People With Type 1 Diabetes","French National Cohort of People With Type 1 Diabètes: the SFDT1 Study","SFDT1","1. Inclusion Criteria\n\n   * Adults and children (age \\>= 6 years)\n   * Type 1 diabetes, defined as:\n   * Age at diagnosis of diabetes \\> 1 year and \\\u003C= 35 years\n   * Insulin treatment initiated within the first 12 months following diabetes discovery\n   * Affiliation to the French social security scheme (RIPH-2 constraint)\n   * Ability to speak and read French\n   * Ability to give written informed consent\n2. Non-inclusion Criteria Patient under guardianship or protection for vulnerable people","6 Years","100 Years",{"count":288,"type":22},15000,"10 Years","Cardiovascular (CV) diseases are the most frequent type 1 diabetes (T1D) complications. A recent epidemiological study showed that patients with T1D have a two-fold CV mortality risk, even in case of good glycemic control. In addition, it has been shown that patients with T1D with no traditional CV risk factors had about a 80% higher risk of cardiovascular event compared to non-diabetic individuals. This indicates that further modifiable risk factors in relation to CV mortality remain to be identified.\n\nOne of the candidates that could help to disentangle the factors associated with the increased CV mortality in T1D patients is glycemic variability which could contribute to diabetes complications. Indeed, severe hypoglycaemia, one of the most severe consequence of glycaemic variability, are associated with a higher mortality in patients with type 1 and type 2 diabetes.\n\nIn order to evaluate the relation between glycemic variability, insulin therapy modalities and CV risk as well as some other questions related to health determinants of T1D, we are building up a large observational, prospective, multi-centric cohort study of patients gathering 15,000 patients with T1D, age above 6 years old, to perform the following:\n\n* Collecting clinical information\n* Evaluating Glycemic variability (assessed by the coefficient of variation of glucose (CV) calculated from automatically downloaded continuous glucose monitoring data (CGM)\n* Biobanking including plasma, DNA, urine, saliva and hair.\n* Collecting patients' reported outcomes through auto-questionnaires (online questionnaires).\n* Doing an active follow-up for a period of 10 years with an intermediate visit every 3 years.\n* Passive follow-up: link to national Health data system (Système National de Données de Santé, SNDS) in order to exhaustively collect health events as death, CV events and hospitalizations (including severe hypoglycemia).",[292,35,293,32],"Diabetes Mellitus, Type 1","Hypoglycemia",[295,296,297,298,299,300],"type 1 diabetes","cardiovascular disease","glucose variability","hypoglycemia","quality of life","insulin therapy","2023-02-13",{"date":303,"type":70},"2023-02-15",{"date":305,"type":70},"2020-06-10",{"date":307,"type":22},"2035-06-10",{"name":309,"class":116},"Fondation Francophone pour la Recherche sur le Diabete"]